What We're Reading: Page
Industry reads hand-picked by our editors
Jul 13, 2026
-
The Financial Times
AstraZeneca CEO: ‘Biology will catch up with me at some point’
-
CNBC
Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer, CEO tells CNBC
-
NBC News
Dozens hospitalized with cyclosporiasis as cases of gastrointestinal illness spike in 31 states
Jul 10, 2026
-
The Wall Street Journal
U.S. Biotechs Are Keeping More Secrets to Beat Copycats in China
-
The Atlantic
The Genes That Could Cancel Out a Fatal Diagnosis
-
Bloomberg
Biotech M&A Surge Seen as Going Beyond Blockbuster Deals
Jul 09, 2026
Jul 08, 2026
-
The New York Times
Plaintiff for Anti-Vaccine Group’s Suit Is Charged With Murder of Her Twins
-
Fierce Biotech
As US lawmakers increase scrutiny of Chinese trials, industry fears ‘huge distraction and expense’
-
CNBC
Employers aren’t expanding coverage of GLP-1 obesity drugs – many are finding ways around it
Jul 07, 2026
Jul 06, 2026
-
The Wall Street Journal
Drugmaker Ipsen Sees More Deals Coming to Continue Buying Spree
-
Houston Business Journal
Houston biotech, pharma deals rise after VC funding ups and downs
-
Stat
I spoke to Anthropic’s CEO about how AI may affect biotech. Here’s what I learned
Previous
